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1. Introduction 
Transgenic plants are the results of modern biotechnology. Biotechnology represents "any 
technological application that uses biological systems, living organisms, or derivatives thereof, 
to make or modify products or processes for specific use” as it was defined by the United 
Nations Convention on Biological Diversity. So, modern biotechnology represents the 
technology by which the genetic material of an organism is modified. This technique can be 
applied to micro-organisms, plants, animals and even to humans. This modern technology by 
which the genes are transferred from one organism to another is called genes technology, 
genetic modification, genetic engineering or bioengineering and the transferred genes are 
called transgenes. The receptor organism, which is transformed by the insertion of the new 
genes into its genome, is named transgenic organism or genetic modified organism. The donor 
and receptor organisms may belong to very different species which can not cross by natural 
means. This fact makes the differentiation of the modern biotechnology by the conventional 
amelioration techniques. So, the transgenic organisms can not be obtained free in nature, in 
natural breeding, they can be obtained just with the help of modern biotechnologies. 
Genetic engineering appeared as an own scientific discipline at the beginnings of ’70 and till 
today it has many definitions, but the most comprehensive looks to be the following: genetic 
engineering represents an ensemble of methods and technologies made “in vitro” with 
genes, chromosomes and some times with entire cells, on the purpose of “building” of some 
new genetic structures with premeditated hereditary properties (Popa L. and col., 1982, as 
cited Vlaic A., 1998). 
Genetic engineering has created two new concepts such as: genetic modified organism and 
the term of transgenesis. 
The concept of genetic modified organism represents a legislative term which groups all the 
organisms resulted by genetic engineering techniques, obtained by different methods of 
genetic recombinations. 
The transgenic organism term implies the incorporation of some exterior genes, considered 
as useful, obtained by the recombinant DNA technology in the genome of some zygotes, 
resulting transgenic organisms with modified genetical properties. This gene transfer is 
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called transgenesis because it presumes crossing the barriers (transgression) meaning the 
gene transfer between different species, especially belonging to different genus (a human 
gene transferred in the bacteria genome, a bacterial gene transferred into the genome of a 
plant or animal). 
Practically the term of genetic modified organism designate every organism of which 
genetic patrimony was modified using the specific methods of genetic engineering. 
2. Obtaining of the genetic modified plants (transgenic plants) 
The genetic manipulation of plants has been going on since the dawn of agriculture, but until 
recently this has required the slow and tedious process of cross-breeding varieties. Genetic 
engineering promises to speed the process and broaden the scope of what can be done. 
Progress is being made on several fronts to introduce new traits into plants using 
recombinant DNA technology. Recombinant DNA is DNA that has been created artificially. 
DNA from two or more sources is incorporated into a single recombinant molecule. 
In order to obtain transgenic plants it is necessary to perform the following steps: 
a. transfer of the gene of interest in the host cell; 
b. selection of the host cells which have integrated the transgenes in their genome;  
c. regeneration of some whole plants, starting from plantulas obtained by „in vitro” 
cultivation of the host cells; 
d. cultivation of the transgenic plants in protected environments (green houses, etc.). 
e. experimental cultivation of the new plants in the fields. 
Each step of the operation requires some special aspects, such as: 
a. transfer of the foreign gene of interest in the genome of the vegetal cell can be realized 
both indirectly or directly.  
The indirect technique presume the using of a biologic vector, represented by some bacteria, 
plasmids or viruses, capable to introduce, naturally, a part of their DNA in the host cells, 
which provides new properties for the receptor plant. The direct method uses some 
techniques as the cellular microinjection of the recombinant DNA or the electro-perforation 
of the cellular membrane by electric shocks which produce micro-pores allowing the 
transgenic DNA to penetrate the new cell. 
b. Selection of the host cells of the gene of interest, no matter the transfer method used. The 
success rate is always very low and for this reason it is necessary to associate the gene of 
interest with a marker gene, favorising the selection of the cells in which the transgene 
was integrated. The most used marker genes by the transgenic seeds producers are the 
ones which are codifying the resistance against an antibiotic or herbicide.  
c. The regeneration and the cultivation of the transgenic plants in protected areas are 
made after they have been obtained in vitro. The plants obtained by cultivation in vitro, 
must be transferred into green houses or rooms with controlled climate. This process 
must be repeated for several generations, to control the expression of the new character, 
its hereditary transmission and the absence of the unwanted effects. 
d. The experimental cultivation in field has the main aim to test the behavior of the new 
transgenic plant in natural conditions. Another aim is to cross the transgenic plant with 
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the conventional elite type (with the best performances at the time), to obtain varieties 
of GMO with an increase productive efficiency. Theoretically speaking, at least, these 
experimental cultures should also evaluate the impact of the GMO regarding the 
environment and human health. 
All the experimental cultures of transgenic plants are conditioned by an authorization 
issued by a group of official experts. The name of the transgenic plant, the nature of the 
experiment, the location and the dimensions of the cultivated experimental areas must be 
communicated to the local authorities and to the public. In average, about one decade passes 
between the first laboratory manipulations and the commercial cultivation of the plants, all 
these experiments being done with high costs. 
Finally, we still mention that all the transgenic plants are protected by industrial type 
registered marks. All the farmers who buy GM seeds are obliged, by contract, not to keep a 
part of their crop for seeds and the penalties for nonobservance of the law are very high. 
3. New properties of the transgenic plants 
The obtaining and, after this, the production of the transgenic plants, with commercial aim, 
determined a lot of enthusiasm within the researchers. The initial enthusiasm was then 
followed by the opposition of the skeptics, who tried, during the time, to argue against the 
cultivation of transgenic plants. 
The supporters of transgenic plants cultivation base their arguments on the new properties 
of the transgenic plants. Among these, the most important are: resistance against the 
herbicides (more than half of the tries), followed by the resistance against the illnesses 
(mostly the viral ones) and against the insects.  
We will shortly describe now the properties of transgenic plants already cultivated on a 
large scale. 
a. Resistance against the herbicides 
It is manifested by the capacity of the plant to live and to develop after it was sprayed with a 
strong insecticide substance. This property is due to the transfer of the Bar gene which 
determines different enzymatic actions materialized by the transformation of the herbicide 
into a non toxic element. In the case of transgenic plants, the resistance against the 
herbicides is uni-specific, so the plant is resistant only against the herbicide for which it was 
created and for this reason the producer of the transgenic plant delivers also the 
characteristic herbicide for each transgenic plant. 
b. Resistance against the insect pests 
The plants having this property are permanently synthetize in their tissue an insecticide 
protein that determine the death of the phytophage insects. The gene codifying the 
resistance against the insects originates in a soil bacteria named Bacillus thuringiensis. Bacillus 
thuringiensis is a bacterium that is pathogenic for a number of insect pests. The lethal effect is 
determined by a proteic toxine which is produced. Through recombinant DNA methods, the 
toxin gene can be introduced directly into the genome of the plant where it is expressed and 
provides protection against insect pests of the plant. 
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c. Resistance against illnesses 
Genes that provide resistance against plant viruses have been successfully introduced into 
such crop plants as tobacco, tomatoes, and potatoes. By transferring the gene codifying the 
protein of the viral capside there were obtained plants resistant against the illnesses produced 
by some viruses because it blocks the propagation of the viruses in the transgenic plant. 
d. Resistance against freezing 
Even not on a large scale, but there were obtained GMO resistant against freezing. This type 
of resistance was obtained by two methods. First, the conventional cultures (especially 
strawberries) were treated with transgenic “antifreezing” bacteria. The second method 
consisted in insertion of some genes obtained from fish living in cold water, as Hippoglossus 
hippoglossus, a fish living in the North Sea, transferred into strawberries. 
e. Improved nutritional quality 
Milled rice is the staple food for a large fraction of the world's human population. Milling 
rice removes the husk and any beta-carotene it contained. Beta-carotene is a precursor to 
vitamin A, so it is not surprising that vitamin A deficiency is widespread, especially in the 
countries of Southeast Asia. The synthesis of beta-carotene requires a number of enzyme-
catalyzed steps. In January 2000, a group of European researchers reported that they had 
succeeded in incorporating three transgenes into rice that enabled the plants to manufacture 
beta-carotene in their endosperm. 
f. Delayed maturation 
This property was first conferred to tomatoes. In this case, there were also used two main 
methods: 
- insertion of a gene that blocks the galacturonase, an enzyme producing the fruits 
softening; 
- blockage of the maturating hormone synthesis; the maturation is than started by 
treatment with ethylene before transferring on the market. 
g. Salt tolerance 
A large part of the land is so laden with salt that it cannot be used to grow most important 
crops. However, researchers at the University of California Davis campus have created 
transgenic tomatoes that grow well in saline soils. The transgene was a highly-expressed 
sodium/proton antiport pump that sequestered excess sodium in the vacuole of leaf cells.  
Due to the new properties of the transgenic plants, their supporters have valid commercial 
arguments to support their production, cultivation and trading. 
4. Advantages of transgenic plants presented by their producers and 
supporters 
The supporters of transgenic plants producing and trading say that these have a lot of 
advantages both for producers, for farmers, for industry, for consumers and for the 
environment and the human future.  
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a. For the producers of the new varieties 
A high efficiency in plants amelioration is obtained. The techniques of gene transfer are 
more precise because they allow the insulation and the propagation of the interest gene, 
while the classical hybridization techniques use the entire parental genomes and for this 
reason are needed back-crossings to emphasize the manifestation of a parental gene or to 
eliminate some secondary unwanted effects determined by the action of the gene in the 
genome. Furthermore, the number of the new characters susceptible to be conferred by gene 
transfer is much higher because the entire genetic information could be used despite its 
origin (viral, bacterial, vegetal or even human). 
b. For farmers 
First of all, the process of pests destroying is simplified due to the elimination of herbicides 
in the pre-emergent period and in the vegetation period. For the GMO only one total 
herbicide is necessary. 
On the other hand, the production output is increasing as well as the profits of the 
transgenic cultures, even the obtaining cost of the GMO is rather high. 
c. For industry 
Due to the new properties of the transgenic plants, their processing could be also improved, 
as is the case of the modified starch, of low lignin content wood (in this case the paper 
manufacturing is less pollutant), of bio-plastics, of some human protein production (easier 
and in higher quantities, for therapeutic aim). 
d. For consumers 
Nowadays the fruits and the vegetables with delayed maturation are easier stored, with 
minimum losses. The maturation moment can be controlled according to the demands of the 
market. 
In the future it is considered that transgenic plants can determine an improved human 
health due to the higher content of vitamins, minerals, essential aminoacids, by using the 
vaccine plants, the rice enriched in pro-vitamin A, etc. 
e. For the environment and human future 
First of all, transgenic plants imply lower pollution due to lower quantities of pesticides. 
Then, higher agricultural productions are obtained and people hope to eliminate the 
starving in the world (by extension of the areas cultivated with GMO resistant against salted 
soils, acid soils, lower temperatures, etc.) 
5. Risks related to the cultivation of the transgenic plants 
Despite of their advantages, it seems that the obtaining and mostly the cultivation of 
transgenic plants also imply some risks. The most important risks are the followings: 
a. Risks related to the nowadays techniques of vegetal gene transfer 
 Secondary unwanted effects. The first obtained transgenic tomato with delayed 
maturation was floury, with metallic taste and difficult to be transported due to its very 
fragile skin. Due to these reasons, the American consumers rejected it. 
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 “weaknesses” in the transgene expression. For example, in USA, in 1996, the fields with 
transgenic cotton were destroyed in proportion of about 60% by some insects against 
which the plants were considered to be resistant. Similar, also in cotton, after the second 
treatment with herbicide it was noticed a deformation of the capsule. This could have 
happened because the producers have had no enough time to check the stability of the 
transgenic character on an enough great number of experimental fields. 
b. Ambiental risks 
 Limitation of the risk evaluation by experimental cultures 
 Risks related to the health, materialized by some allergies and resistance to some 
antibiotics. 
 Risks related to the biodiversity of the ecosystems by  
 dissemination of the transgenic pollen to the similar spontaneous plants; 
 crossings between transgenic and conventional varieties of species; 
 apparition of some pest plants resistant against total herbicides 
 Risks related to plants resistant to the insects attack: 
 apparition of some pests resistant against the insecticide-protein of the Bt maize; 
 intoxication of other insects by the transgenic plants 
 toxicity for the enemies of the pest insects. 
 Risks regarding the circuit of the insecticide toxins in soils and in the trophic chains; 
 Risks determined by the cultivation techniques of the plants resistant against herbicide, 
insects, viruses. 
 Risk of destruction of the spontaneous flora and of the plants in the neighborhood of 
the cultivated fields, by the total herbicides. 
6. Cultivation of the genetic modified plants worldwide 
The first commercial transgenic plants cultures started in the middle of 1990 years, in USA, 
where they had the fastest evolution.  
Immediately after followed Argentina and Canada, where the increasing of the surfaces 
cultivated with transgenic plants stabilized beginning with 1999. Both countries were 
followed by Brazil and China. 
After only 7 years from their official start, the commercial cultures of transgenic plants 
reached a total surface of 60 million ha at which we could add the illegal GM soy cultures in 
Brazil of about 1 million ha. 
During the fourteen years of commercialization 1996 to 2009, the global area of biotech crops 
increased almost 80-fold (78.8), from 1.7 million hectares in 1996 to 134 million hectares in 
2009. This rate of adoption is the highest rate of crop technology adoption for any crop 
technology and reflects the continuing and growing acceptance of biotech crops by farmers 
in both large as well as small farms and resource-poor farmers in industrial and developing 
countries. In the same period, the number of countries growing biotech crops quadrupled , 
increasing from 6 in 1996 to 12 countries in 1999, 17 in 2004, 21 countries in 2005, and 25 in 
2009 (Clive J., 2010). 
www.intechopen.com
Transgenic Plants – Advantages Regarding  
Their Cultivation, Potentially Risks and Legislation Regarding GMO’s 
 
415 
Taking into account that approximately 21% of the 134 million hectares had two or three 
traits (planted primarily in the USA, but also increasingly in ten other countries, Argentina, 
Canada, the Philippines, South Africa, Australia, Mexico, Chile, Colombia, Honduras, and 
Costa Rica), the true global area of biotech crops in 2009 expressed as “trait hectares” was 
180 million compared with 166 million “trait hectares” in 2008. Thus, the real growth rate 
measured in “trait hectares” between 2009 (180 million) and 2008 (166 million) was 8% or 14 
million hectares compared with the apparent growth rate of 7% or 9 million hectares when 
measured conservatively in hectares between 2008 (125 million hectares) and 2009 (134 
million hectares). (Clive J., 2010). 
The list of the higher transgenic plants which are produced includes: (http://www.molecular-
plant-biotechnology.info/transgenic-plants/list-of-higher-plants-where-transgenic-plants-
have-been-produced.htm) 
Herbaceous dicotyledons, such as: Nicotiana tabacum (tobacco), N. plumbaginifolia (wild 
tobacco), Petunia hybrida (petunia), Lycopersicon esculentum (tomato), Solanum tuberosum 
(potato), Solanum melongena (eggplant), Arabidopsis thaliana, Lactuca sativa (lettuce), 
Apium graveolens (celery), Helianthus annuus (sunflower), Linum usitatissimum (flax), 
Brassica napus (oilseed rape; canola), Brassica oleracea (cauliflower), Brassica oleracea var 
(cabbage), Brassica rapa (syn. B. campestris), Gossypium hirsutum (cotton), Beta vulgaris 
(sugarbeet), Glycine max (soybean), Pisum sativum (pea), Medicago sativa (alfalfa), M. 
varia, Lotus corniculatum (lotus), Vigna aconitifolia, Cucumis sativus (cucumber), Cucumis 
mew (muskmelon), Cichorium intybus (chicory), Daucus carota (carrot), Armoracia sp. 
(horse radish), Glycorrhiza glabra (licorice), Digitalis' purpurea (foxglove), Ipomoea batatas 
(sweet potato), Ipomoea purpurea (morning glory), Fragaria sp. (strawberry), Actinidia sp. 
(Kiwi), Carica papaya (papaya), Vitis vinifera (grape), Vaccinium macrocarpon (cranberry), 
Dianthus caryophyllus (carnation), Chrysallthemum sp. (chrysanthemum), Rosa sp. (rose); 
Woody dicotyledons: Populus sp. (poplar), Malus sylvestris (apple), Pyrus communis 
(pear), Azadirachta indica (neem), Juglans regia (walnut); 
Monocotyledons: Asparagus sp. (asparagus), Daclylis glomerata (orchard grass), Secale 
cereale (rye), Oryza sativa (rice), Triticum aestivum (wheat), Zea mays (corn), Avena sativa 
(oats), Festuca arundinacea (tall fescue); 
Gymmosperms (a conifer) Picea glauca (white spruce). 
Analysing the list it can be noticed that nowadays genetic engineering helped the producing 
of a wide scale of different types of plants but just a few of them are nowadays cultivated at 
large scale. 
The worldwide market of transgenic plants consists almost exclusively, in four species: soy, 
cotton, maize and rapes. The other transgenic plants (potato, papaya, tobacco, pumpkin) are 
cultivated only on small surfaces, non-relevant for the total cultivated ones. 
The list of the EU registered GM products which are used as food or food additives 
comprise the following plants:  
(http://ec.europa.eu/food/dyna/gm_register/index_en.cfm) 
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- Soybean (MON40-3-2), MON-Ø4Ø32-6, Monsanto, genetically modified soybean that 
contains: cp4 epsps gene inserted to confer tolerance to the herbicide glyphosate. 
- Soybean (A2704-12), ACS-GMØØ5-3, Bayer, genetically modified soybean that 
contains: pat gene inserted to confer tolerance to the glufosinate-ammonium herbicide. 
- Soybean (MON89788), MON-89788-1, Monsanto, genetically modified soybean that 
contains: cp4 epsps gene inserted to confer tolerance to the herbicide glyphosate. 
- Cotton (MON1445), MON-Ø1445-2, Monsanto, genetically modified cotton that 
contains: cp4 epsps gene inserted to confer tolerance to the herbicide glyphosate. 
- Cotton (MON15985) MON-15985-7, Monsanto, genetically modified cotton that 
contains: cry1Ac and cry2Ab2 genes inserted to confer insect-resistance highly selective 
in controlling Lepidopteran insects. 
- Cotton (MON15985 x MON1445), MON-15985-7 x MON-Ø1445-2, Monsanto, 
Genetically modified cotton that contains: cry1Ac and cry2Ab2 genes inserted to confer 
insect-resistance highly selective in controlling Lepidopteran insects and cp4 epsps gene 
inserted to confer tolerance to the herbicide glyphosate. 
- Cotton (MON531), MON-ØØ531-6, Monsanto, genetically modified cotton that 
contains: cry1A(c) gene inserted to confer insect-resistance. 
- Cotton (MON531 x MON1445 ), MON-ØØ531-6 x MON-Ø1445-2, Monsanto, 
Genetically modified cotton that contains: cry1A(c) gene inserted to confer insect-
resistance and cp4 epsps gene inserted to confer tolerance to the herbicide glyphosate. 
- Cotton (LLCotton25), ACS-GHØØ1-3, Bayer, genetically modified cotton that contains: 
pat gene inserted to confer tolerance to the glufosinate-ammonium herbicide. 
- Cotton (GHB614), BCS-GHØØ2-5, Bayer, genetically modified cotton that expresses: 
2mepsps gene inserted to confer tolerance to the glyphosate herbicides. 
- Maize (Bt11), SYN-BT Ø11-1, Syngenta, genetically modified maize that contains: the 
cryIA (b) gene inserted to confer insect-resistance and the pat gene inserted to confer 
tolerance to the herbicide glufosinate-ammonium. 
- Maize (DAS59122), DAS-59122-7, Pioneer and Dow AgroSciences, genetically modified 
maize that contains: the cry34Ab1 and cry35Ab1 genes inserted to confer protection 
against certain coleopteran pests such as corn rootworm larvae (Diabrotica spp.) and 
pat gene inserted to confer tolerance to the glufosinate-ammonium herbicide. 
- Maize (DAS1507), DAS-Ø15Ø7-1, Pioneer and Dow AgroSciences, genetically modified 
maize that contains: cry1F gene inserted to confer resistance to the European corn borer 
and certain other lepidopteran pests and pat gene inserted to confer tolerance to the 
herbicide glufosinate-ammonium. 
- Maize (DAS1507xNK603), DAS-Ø15Ø7-1xMON-ØØ6Ø3-6, Pioneer and Dow 
AgroSciences, genetically modified maize that contains: cry1F gene inserted to confer 
protection against certain lepidopteran pests such as the European corn borer (Ostrinia 
nubilalis) and species belonging to the genus Sesamia, pat gene inserted to confer 
tolerance to the glufosinate-ammonium herbicide and cp 4epsps gene inserted to confer 
tolerance to the glyphosate herbicide. 
- Maize (GA21), MON-ØØØ21-9, Syngenta, genetically modified maize that contains: 
mepsps gene inserted to confer tolerance to herbicide glyphosate. 
- Maize (MON810) , MON-ØØ81Ø-6, Monsanto, genetically modified maize that 
contains: cryIA (b) gene inserted to confer resistance to lepidopteran pests.  
- Maize (MON863), MON-ØØ863-5, Monsanto, genetically modified maize that contains: 
a trait gene cry3Bb1 inserted to confer insect- resistance and nptII gene inserted as a 
selection marker. 
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- Maize (NK603), MON-ØØ6Ø3-6, Monsanto, genetically modified maize that contains: 
cp4 epsps gene inserted to confer tolerance to the herbicide glyphosate. 
- Maize (NK603 x MON810), MON-ØØ6Ø3-6 x MON-ØØ81Ø-6, Monsanto, genetically 
modified maize that contains: cp4 epsps gene inserted to confer tolerance to glyphosate 
herbicides and the cry1Ab gene inserted to confer protection against certain 
lepidopteran insect pests (Ostrinia nubilalis, Sesamia spp.). 
- Maize (T25), ACS-ZMØØ3-2, Bayer, genetically modified maize that contains: pat gene 
inserted to confer tolerance to the herbicide glufosinate-ammonium. 
- Maize (MON88017), MON-88Ø17-3, Monsanto, genetically modified maize that 
contains: modified cry3Bb1 gene inserted to confer protection to certain coleopteran 
pests and cp4 epsps gene inserted to confer tolerance to glyphosate herbicides. 
- Maize (MON89034), MON-89Ø34-3, Monsanto, genetically modified maize that contains: 
cry1A.105 and cry2Ab2 genes inserted to confer protection to certain lepidopteran pests. 
- Maize (59122xNK603), DAS-59122-7xMON-ØØ6Ø3-6, Pioneer, genetically modified 
maize that contains: cry34Ab1 and cry35Ab1 genes inserted to confer protection against 
certain coleopteran pests; pat genes inserted to confer tolerance to the glufosinate-
ammonium herbicides and cp4 epsps genes inserted to confer tolerance to glyphosate 
herbicides. 
- Maize (MIR604), SYN-IR6Ø4-5, Syngenta, genetically modified maize that contains: 
modified cry3A gene inserted to confer protection against certain coleopteran pests and 
pmi gene inserted as selection marker. 
- Maize (MON863xMON810xNK603) , MON-ØØ863-5xMON-ØØ81Ø-6xMON-ØØ6Ø3-
6, Monsanto, genetically modified maize that contains: cry3Bb1 gene inserted to confer 
protection against certain coleopteran pests; cry1Ab gene inserted to confer protection 
against certain lepidopteran insect pests; cp4 epsps gene inserted to confer tolerance to 
glyphosate herbicides and nptII gene inserted as a selection marker. 
- Maize (MON863 x MON810 ) , MON-ØØ863-5 x MON-ØØ81Ø-6, Monsanto, 
genetically modified maize that contains: cry3Bb1 gene inserted to confer protection 
against certain coleopteran pests; cry1Ab gene inserted to confer protection against 
certain lepidopteran insect pests and nptII gene inserted as a selection marker. 
- Maize (Bt11xGA21), SYN-BTØ11-1xMON-ØØØ21-9, Syngenta, genetically modified 
maize that expresses: the cry1Ab gene which confers protection against certain 
lepidopteran pests ; the pat gene which confers tolerance to the glufosinate-ammonium 
herbicides and the mepsps gene which confers tolerance to glyphosate herbicides. 
- Maize (MON863 x NK603), MON-ØØ863-5 x MON-ØØ6Ø3-6, Monsanto, genetically 
modified maize that contains: cry3Bb1 gene inserted to confer protection against certain 
coleopteran pests; cp4 epsps gene inserted to confer tolerance to glyphosate herbicides 
and nptII gene inserted as a selection marker. 
- Maize (MON88017xMON810), MON-88Ø17-3xMON-ØØ81Ø-6, Monsanto, genetically 
modified maize that expresses: the cry1Ab gene which confers protection against certain 
lepidopteran pests ; the cry3Bb1 gene which provides protection to certain coleopteran 
pests and the cp4 epsps gene which confers tolerance to glyphosate herbicides. 
- Maize (MON89034 xNK603), MON-89Ø34-3x MON-ØØ6Ø3-6, , Monsanto, genetically 
modified maize that expresses: the cry1A.105 and cry2Ab2 genes which provide 
protection to certain lepidopteran pests and the cp4 epsps gene which confers tolerance 
to glyphosate herbicides. 
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- Maize (59122x1507xNK603), DAS-59122-7xDAS-Ø15Ø7xMON-ØØ6Ø3-6, Pioneer, 
genetically modified maize that expresses: the cry1F gene which confers protection 
against certain lepidopteran pests; the cry34Ab1 and cry35Ab1 genes which provide 
protection to certain coleopteran pests; the pat gene which confers tolerance to the 
glufosinate-ammonium herbicides and the cp4 epsps gene which confers tolerance to 
glyphosate herbicides. 
- Maize (1507x59122), DAS-Ø15Ø7x DAS-59122-7, Pioneer, genetically modified maize 
that expresses: the cry1F gene which confers protection against certain lepidopteran 
pests; the cry34Ab1 and cry35Ab1 genes which provide protection to certain 
coleopteran pests and the pat gene which confers tolerance to the glufosinate-
ammonium herbicides. 
- Maize (MON89034 xMON88017), MON-89Ø34-3x MON-88Ø17-3, Monsanto, 
genetically modified maize that expresses: cry1A.105 and cry2Ab2 genes which provide 
protection to certain lepidopteran pests; cry3Bb1 gene which provides protection to 
certain coleopteran pests and cp4 epsps gene which confers tolerance to glyphosate 
herbicides. 
- Oilseed rape (GT73), MON-ØØØ73-7, Monsanto, genetically modified oilseed rape that 
contains: cp4 epsps and goxv247 genes inserted to confer tolerance to the herbicide 
glyphosate. 
- Oilseed rape (T45), ACS-BNØØ8-2, Bayer, genetically modified oilseed rape that 
contains: pat gene inserted to confer tolerance to the herbicide glufosinate-ammonium. 
- Swede-rape (MS8, RF3, MS8xRF3), ACS-BNØØ5-8ACS-BNØØ3-6ACS-BNØØ5-8 x 
ACS-BN003-6, Bayer, genetically modifieds oilseed rape that contains:a bar (pat) gene 
inserted to confer tolerance to herbicides based on glufosinate ammonium; barnase 
gene inserted to leads to lack of viable pollen and male sterility and barstar gene 
inserted to leads to lack of viable pollen and male sterility. 
- Starch potato (EH92-527-1), BPS-25271-9, BASF, genetically modified starch potato that 
contains: an inhibited gbss gene responsible for amylase biosynthesis. As a result, the 
starch product has little or no amylase and consists of amylopectin and nptII gene 
inserted as a selection marker. 
- Sugar beet (H7-1), KM-ØØØ71-4, KWS SAAT and Monsanto, genetically modified 
sugar beet that expresses: a CP4 EPSPS protein confers tolerance to glyphosate 
containing herbicides. 
Beside the GMO plants there also exist genetic modified microorganisms, such as: 
(http://ec.europa.eu/food/dyna/gm_register/index_en.cfm) 
Bacterial biomass, (pCABL- Bacterial biomass ), Ajinomoto Eurolysine SAS, Bacterial 
protein, by-product from the production by fermentation of L-Lysine HCl obtained from 
(Brevibacterium lactofermentum) the recovered killed microorganisms. The source is the 
Brevibacterium lactofermentum strain SO317/pCABL, used for feed produced from GMO 
bacteria: " bacterial biomass". 
Yeast biomass, (pMT742 or pAK729-Yeast biomass ), NOVO Nordisk A/S, NOVO Yeast 
Cream is a product produced from genetically modified yeast strains (Saccharomyces 
cerevisiae) cultivated on substrates of vegetable origin. The source is the Saccharomyces 
cerevisiae strain MT663/pMT742 or pAK729, used for feed materials produced from GMO 
yeast: "yeast biomass". 
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The global impact of the genetic modified plants presents the following aspects 
(www.biotech-gmo.com): the additional brut margin realized by the farmers by cultivation of 
the genetic modified plants is of 22 billion USD, and the reduction of the pesticides 
quantities applied on the soil for the modified plants is about 172 million kg, resulting an 
impact coefficient on the environment of 14%. 
Herbicide tolerance continues to be the most common transgenic trait. Herbicide tolerance is 
available for all of the major GM crops, including soybean, maize, rapeseed, and cotton. In 
2005, the first herbicide tolerant sugar beets were approved in the US, Australia, Canada, 
and the Philippines. Herbicide tolerant rice and wheat already have been developed, but 
currently are not in use. In 2006, there was wide cultivation of herbicide tolerant alfalfa for 
the first time in the USA (80,000 hectares). In most of the cases the tolerance is to the 
following herbicides glyphosate (Roundup) or glufosinate-ammonium (Liberty). Such crops 
make up 70 percent of the 102.0 million hectares of GM crops worldwide (2006).  
(http://www.gmo-compass.org/eng/agri_biotechnology/gmo_planting/145.gmo_ 
cultivation_trait_statistics.html) 
 
Global area of genetically engineered crops, 1996 to 2006: By trait (million hectares) 
Trait HT IR (Bt) IR/HT VR/Others Total 
1996 0.6 1.1 -- <0.1 1.7 
1997 6.9 0.4 <0.1 <0.1 11.0 
1998 19.8 7.7 0.3 <0.1 27.8 
1999 28.1 8.9 2.9 <0.1 39.9 
2000 32.7 8.3 3.2 <0.1 44.2 
2001 40.6 7.8 4.2 <0.1 52.6 
2002 44.2 10.1 4.4 <0.1 58.7 
2003 49.7 12.2 5.8 <0.1 67.7 
2004 58.6 15.6 6.8 <0.1 81.0 
2005 63.7 16.2 10. <0.1 90.0 
2006 69.9 19.0 13.1 <0.1 102.0 
Source: ISAAA, Clive James, 2006. 
 
HT Herbicide tolerance 
IR Insect resistance (mostly Bt) 
VR Resistance to virus diseases 
Table 1. Global area of genetically engineered crops 
Insect resistance is the second most common genetically modified trait. Herbicide tolerance 
and insect resistance (Bt) often are introduced simultaneously to a crop in one 
transformation event. This is called trait stacking. The third most commonly grown 
transgenic crop was stacked insect resistant/herbicide tolerant maize. Combined herbicide 
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and insect resistance was the fastest growing GM trait from 2004 to 2005, grown on over 6.5 
million hectares in the US and Canada and comprising seven percent of the global biotech 
area. The recent expansion of Bt crops is mainly due to the increasing Bt maize and Bt cotton 
production in China, India, and Australia (Table 1 and 2). 
 
Trait-crop combinations, 1996 to 2005 (million hectares) 
Trait 
IR 
maize 
HT 
maize 
IR/HT 
maize 
IR/HT 
cotton 
HT 
cotton 
IR 
cotton 
1996 0.3 0.0 -- 0.0 < 0.1 0.8 
1997 3.0 0.2 -- < 0.1 0.4 1.1 
1998 7.0 2.0 -- -- -- 1.0 
1999 7.5 1.5 2.1 0.8 1.6 1.3 
2000 6.8 2.1 1.4 1.7 2.1 1.5 
2001 5.9 2.4 2.5 1.9 1.8 2.1 
2002 7.7 2.5 2.2 2.2 2.2 2.4 
2003 9.1 3.2 3.2 2.6 1.5 3.1 
2004 11.2 4.3 3.8 3.0 1.5 4.5 
2005 11.3 3.4 6.5 3.6 1.3 4.9 
2006 -- -- -- -- -- 3.8 
Source: ISAAA, Clive James, 2006. 
 
HT Herbicide tolerance 
IR Insect resistance (mostly Bt) 
VR Resistance to virus diseases 
Table 2. Trait –crop combinations in GMOs 
7. Legislation regarding the transgenic plants 
The purpose of a legislation system regarding the utilisation and cultivation of transgenic 
organisms obtained by modern biotechnology is the protection of the environment and the 
human health. The legislation has a preventive role and not a corrective one. 
The legislation regulating the obtaining, testing, utilisation and commercialisation of the 
organisms obtained by modern biotechnology was elaborated in 1990 with three main 
objectives: 
- to protect the human and animal health; 
- to protect the environment; 
- to assure the circulation of the GMO in EU; 
The most important legislative act regarding GMO’s in EU is the Directive 2001/18/EC and 
the Regulation (EC) No. 178/2002. 
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7.1 Directive 2001/18/EC 
The directive presents the legislative framework regarding the deliberate release of the 
genetically modified organisms (GMOs) into the environment and the placing of GMOs on 
the market in accordance with the precautionary principle. 
(http://europa.eu/legislation_summaries/agriculture/food/l28130_en.htm). 
The main aim of this Directive is to make the procedure for release and placing on the 
market of genetically modified organisms (GMOs) and to introduce compulsory monitoring 
after GMOs have been placed on the market. 
It also provides a common methodology to assess case-by-case the risks for the environment 
associated with the release of GMOs (the principles applying to environmental risk 
assessment are set out in Annex II to the Directive). 
Public consultation and GMO labelling are made compulsory under the new Directive. 
Rules on the operation of these registers are laid down in Decision 2004/204/EC  
The Directive invited the Commission to present a proposal for implementing the Cartagena 
Protocol on biosafety, which led to the adoption of Regulation (EC) No 1946/2003 on 
transboundary movements of genetically modified organisms. 
The Directive 2001/18/EC had entry into force in 17.4.2001, the deadline for transposition in 
the member states of the EU was 17.10.2002 and the Official Journal in which it was published 
was OJ L 106 of 17.4.2001. The amending acts of Directive 2001/18/EC are represented by two 
regulations, Regulation (EC) No 1829/2003 and Regulation (EC) No 1830/2003, both entering 
into force starting with 07.11.2003, and being published into OJ L 268 of 18.10.2003. 
(http://europa.eu/legislation_summaries/agriculture/food/l28130_en.html). 
7.2 Regulation (EC) No. 178/2002 
Regulation (EC) No. 178/2002 of the European Parliament and of the Council of 28 January 
2002 laying down the general principles and requirements of food law, establishing the 
European Food Safety Authority (EFSA) and laying down procedures in matters of food 
safety.  
This Regulation provides a framework for food and feed Law within the EC. It applies to all 
stages of production, processing and distribution of food and feed, but does not apply to 
primary production for private domestic use or to the domestic preparation, handling or 
storage of food for private domestic consumption. 
(http://www.food.gov.uk/scotland/regsscotland/regulations/scotlandfoodlawguide/sflg
200501/). 
The legislation regarding the authorization for introduction of the GMO’s in the environment 
for the experimental purpose is presented in the Directive 2001/18/EC (part B). 
Important information, regulated in the part C, are about the general aspects of GMO’s 
labelling, free circulation and information to the public.  
(http://www.biosafety.be/GB/Dir.Eur.GB/Del.Rel./2001_18/2001_18_TC.html) 
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7.3 Other legislation regarding GMO’s 
Other legal instruments regarding GMO’s are the followings:  
- Directive 90/220/EEC on the deliberate release into the environment of genetically 
modified organisms entry into force on the 17-th of October 2002; 
- Directive 98/81/EC amending Directive 90/219/EEC regarding the use of GMO’s 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/1998/1_330/1_33019981205en00130031.pdf) 
- Decision 2002/623/EC establishing guidance notes supplementing Annex II to 
Directive 2001/18/EC. 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/2002/1_200/1_20020020730en00220033.pdf) 
- Decision 2002/813/EC115 establishes the format to be used by competent authorities 
when they provide summaries of notifications to the Commission under Article 11 of 
Directive 2001/18/EC. 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/2002/1_280/1_28020021018en00620083.pdf) 
- Decision 2003/701/EC116 establishes the format to be used by notifiers in the reporting 
of the results of the deliberate release to the competent authorities, as required by 
Article 10 of Directive 2001/18/EC 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/2003/1_254/1_25420031008en00210028.pdf) 
- Decision 2002/812/EC establishing pursuant to Directive 2001/18/EC the summary 
information format relating to the placing on the market of genetically modified 
organisms as or in products. 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/2002/1_280/1_28020021018en00370061.pdf) 
- Decision 2004/204/EC laying down detailed arrangements for the operation of the 
registers for recording information on genetic modifications in GMO, provided in 
Directive 2001/18/EC. 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/2002/1_280/1_28020021018en00270036.pdf) 
- Decision 2002/811/EC establishing guidance notes supplementing Annex II to 
Directive 2001/18/EC. 
(http://europa.eu.int/eur-lex/pri/en/oj/dat/2002/1_200/1_20020020730en00220033 
.pdf) 
- Regulation (EC) No. 178/2002 regarding the general principles and requirements of 
food law. 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/2002/1_031/1_03120020201en00010024.pdf) 
- Regulation (EC) No. 1829/2003 on genetically modified food and feed; 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/2003/1_268/1_26820031018en00010023.pdf) 
- Regulation (EC) No. 1830/2003 concerning the traceability and labelling of genetically 
modified organisms and traceability of food and feed products produced from 
genetically modified organisms. 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/2003/1_268/1_26820031018en00240028.pdf) 
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- Regulation (EC) No. 1946/2003 on transboundary movements of genetically modified 
organisms. 
(http://europa.eu.int/eur-
lex/pri/en/oj/dat/2003/1_287/1_28720031105en00010010.pdf) 
8. Genetical modified flowers on the market 
The research regarding the color of the flower is an ongoing process. It was noticed that in 
some plants the blue pigment is lacking, so the blue colored flowers cannot be obtained by 
classical cross-breed techniques. Genetic engineering has allowed scientists to produce 
carnation blue flowers even that the blue pigment is missing.  
Moondust’ carnation, first grown commercially in 1997, is a mini-carnation with purple-
mauve flowers that gets its blue color from petunia genes grafted into the DNA of the 
carnation. Twelve scientists at an Australian company called Florigene labored for a decade 
to isolate the gene responsible for blue color in petunia and then transfer it into the 
carnation.  
To date, they have released five carnations with the "Moon" prefix, all with varying shades 
of mauve (Moonvista), blue (Moonshade), violet (Moonlite) or purple (Monaqua) (Fig.1).  
Roses, carnations, lilies and orchids all lack a class of blue pigments called delphinidins, 
named after the violet-blue we see in delphinium. The gene for delphinidin production is 
what the Florigene scientists removed from petunia and transferred to the carnation. 
(http://www.arhomeandgarden.org/plantoftheweek/articles/blue_carnation.htm) 
 
Moonvista Moonshade Moonlite Moonaqua 
Fig. 1. Florigene blue carnations 
The blue carnations are cultivated in Ecuador, Columbia and Australia and commercialised 
in USA, Canada, Japan, EU and Australia. 
Blue roses were always very desirable flowers because they symbol the mystery, the 
untouchable, being impossible to be produced free in nature. They were avaible on many 
markets, from many years, but they were not real blue roses, because they are traditionally 
created by dyeing white roses with blue dye. 
It was in 2004 when the first blue rose was obtained by genetic engineering (Fig. 2). It was 
the result of the researches made by Japanese (Suntory Limited Research Centre) and 
Australian (Florigene) researchers and the first blue roses were officially presented to the 
specialists and to the market at the World Rose Convention in Osaka 2006.  
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http://www.flowermeaning.info/Blue.php 
Fig. 2. Blue rose presented at World Rose Convention in Osaka, 2006 
The above mentioned researchers observed that the flower color is mainly determined by 
anthocyanins. Rosa hybrida lacks violet to blue flower varieties due to the absence of 
delphinidin-based anthocyanins, usually the major constituents of violet and blue flowers, 
because roses do not possess flavonoid 3′,5′-hydoxylase (F3′5′H), a key enzyme for 
delphinidin biosynthesis. Other factors such as the presence of co-pigments and the 
vacuolar pH also affect flower color.  
It was analyzed the flavonoid composition of hundreds of rose cultivars and measured the 
pH of their petal juice in order to select hosts of genetic transformation that would be 
suitable for the exclusive accumulation of delphinidin and the resulting color change toward 
blue. Expression of the viola F3′5′H gene in some of the selected cultivars resulted in the 
accumulation of a high percentage of delphinidin (up to 95%) and a novel bluish flower 
color.  
For more exclusive and dominant accumulation of delphinidin irrespective of the hosts, the 
researchers down-regulated the endogenous dihydroflavonol 4-reductase (DFR) gene and 
over-expressed the Iris×hollandica DFR gene in addition to the viola F3′5′H gene in a rose 
cultivar. The resultant roses exclusively accumulated delphinidin in the petals, and the 
flowers had blue hues not achieved by hybridization breeding. Moreover, the ability for 
exclusive accumulation of delphinidin was inherited by the next generations. (Yukihisa 
Katsumoto, 2007). 
9. Conclusions 
1. The scientific progress could be not stopped by anyone and by nothing. It is very 
important to use the scientific progress for the whole humanity and to be in 
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concordance with the actual and the future generations’ interest, without supporting 
the interests of only certain groups. This was the starting point of sustainability strategy 
which, in its essence, stipulate that the development is made for people and is realized 
by people. 
2. The ecologic, geographic and antropic assemblies realize the landscape, with very 
important functions of general interest at the cultural, ecological, social level, this 
landscape being an important resource of the human economic activities. In this 
context, it should be mentioned that we don’t know yet all the potential risks that the 
GMO could have, by long term accumulation, upon the environment. 
3. The achievements of the genetic engineering have nowadays considerable benefits, but 
now we don’t know the price we, or the future generations, will have to pay in the 
future for this benefits. The long term risks of the GMO are not entirely known today. 
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